ベンダー
English
search

Supporting ISDA SIMM™: Key Considerations You Need to Know

Email Call back Website
Create a vendor selection project
Click to express your interest in this report
Indication of coverage against your requirements
A subscription is required to activate this feature. Contact us for more info.
Celent have reviewed this profile and believe it to be accurate.
We are waiting for the vendor to publish their solution profile. Contact us or request the RFX.
Projects allow you to export Registered Vendor details and survey responses for analysis outside of Marsh CND. Please refer to the Marsh CND User Guide for detailed instructions.
Download Registered Vendor Survey responses as PDF
Contact vendor directly with specific questions (ie. pricing, capacity, etc)
2019/04/08

Is your institution going to be part of the final two phase-ins of initial margin (IM) rules for non-cleared derivatives?

If so, one of the first decisions that will have to be made is exactly to how calculate IM and exchange it with counterparties. But what you need to know is that the successful implementation of initial margin requirements will require extensive operational and technological overhauls.

Read this paper to become aware of the significant challenges OTC derivatives market participants will face including:

  • Attaining model approval by regulators
  • The development and testing of new processes
  • The need for unified organization-wide preparation
  • The extensive demand on internal and external market resources
  • The technical and functional requirements of ISDA SIMMTM

Download this complimentary Paper here: https://www.numerix.com/white-paper/supporting-isda-simm-considerations-you-need-to-know